Developed domain profile

OXB.com

OXB.COM connects advanced viral-vector development with GMP manufacturing expertise

Research summary

The profile at a glance.

The classification and value describe the domain asset itself. They do not value or imply availability of any operating business.

Current signalOperating use confirmedPublic operating use confirmed
Letter structureVCCVowels and consonants
SequenceUniqueThree distinct letters
Value tierFoundational$45,000–$74,999
Valuation model23/100Intrinsic score · marketability E
Latest scanJul 24, 2026UTC · evidence changes over time
Classification confidenceHighAcquisition-signal confidenceLimitedValue confidenceDeveloping
Why TLL classifies it this way

OXB.COM is identified as the current public web identity of OXB. This current-use classification is separate from TLL's domain-only valuation.

Read the research methodology →
Current digital identity

Website Capture

This is how OXB is currently represented at OXB.COM.

oxb.com
Current website screenshot of OXB at OXB.COM
Identity and market context

OXB.COM Domain Overview

OXB is a cell and gene therapy contract development and manufacturing organization (CDMO) providing end-to-end support for viral-vector therapies. Its services cover process development, GMP manufacturing, analytical methods, and regulatory support across lentivirus, AAV, adenovirus, and other vectors, from pre-clinical work through commercial launch. OXB.COM serves as the organization’s primary online identity, bringing together solution pages, research resources, company information, investor materials, careers, news, and contact pathways in one current corporate destination.

$

Estimated OXB.COM domain value

$45,000–$74,999

OXB benefits from the recognizable “ox” opening, which supplies a modest animal and word-stem association. The final B makes the construction more abrupt and less naturally pronounceable than vowel-ending alternatives. It has no complete dictionary meaning or universal sequence, so its intrinsic value rests on compact acronym utility and the familiarity of its first two letters.

Intrinsic score23/100Marketability gradeEModel statusDirectional estimate
Directional estimate of the domain asset, separate from the current brand or business. Existing trademark associations may limit practical transferability.
Related opportunities

Similar Domains With Acquisition Signals

These domains are privately held and may require direct outreach or brokerage to acquire.

Analyst note

OXB is a tightly compressed three-letter string with a distinctive consonant-led shape. Its spoken form, “O-X-B,” is brief, clear, and easy to reproduce, while the uncommon X in the middle gives the sequence visual contrast and helps separate it from more repetitive initialisms. The letters form a compact uppercase mark, with the diagonal geometry of X adding energy between the rounded O and angular B. OXB functions primarily as an initialism-like mark rather than a dictionary word, making its strength mnemonic rather than literal. OXB.COM identifies OXB’s corporate web presence.
Asset-only research estimate · 2026
Comparable identities

Comparable Developed Identities

DomainAgents
Acquisition partner

Research the Domain.
Contact the Owner.

DomainAgents has facilitated more than 300,000 domain negotiations since 2012.

TLL is free and has no subscription. Owner outreach costs $19.95. When a buyer-initiated acquisition completes, DomainAgents charges a 10% buyer success fee, reduced to 7.5% above $25,000. Public TLL estimates use public signals; private negotiation data is not used.

Explore DomainAgents ↗